The real difference between the two GLP-1 medications, and how a provider decides which one is right for you.
The short version: semaglutide works on one hormone pathway, tirzepatide works on two. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and GIP, which is why it is often described as dual-action.
Both are once-weekly injections. Both start at a low dose and step up gradually under a provider's guidance. Both work by acting on appetite and how full you feel rather than on metabolism directly.
Which one is right for you is a clinical decision, not a shopping decision. A licensed provider weighs your health history, your other medications, how you have responded to treatment before, and your goals. The stronger option is not automatically the better one for a given person.
What actually differs between the two.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Hormone pathways | GLP-1 | GLP-1 and GIP |
| Brand equivalents | Ozempic®, Wegovy® | Mounjaro®, Zepbound® |
| How it is taken | Once-weekly injection | Once-weekly injection |
| Dosing | Starts low, steps up over months | Starts low, steps up over months |
| At Red Lion Clinic | $299 (4 mg) · $399 (10 mg) | $399 (30 mg) · $599 (60 mg) |
Every price includes the provider's care, ongoing check-ins and free shipping. No subscription.
Four things that matter more than which one you have heard of.
Existing conditions and past reactions narrow the field before anything else does.
What you already take affects what can safely be added, and at what dose.
Side effects differ between people, not just between drugs. Dosing is adjusted around what you can actually live with.
How much you are looking to lose, and over what period, changes which option makes sense to start with.
Prices for both are on the cost page. Comparing the brand versions? See Zepbound vs Wegovy cost.
Semaglutide acts on one hormone pathway, GLP-1. Tirzepatide acts on two, GLP-1 and GIP, which is why it is described as dual-action. Both are once-weekly injections that are started at a low dose and increased gradually under provider guidance.
Not automatically, and not for everyone. Tirzepatide's dual-pathway action is why it is often described as the more powerful of the two, but the right choice depends on your health history, your other medications, how you tolerate treatment and your goals. That decision belongs to a licensed provider, not to a comparison table.
Semaglutide is the active ingredient in Ozempic® and Wegovy®. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®. Those are separate, FDA-approved products from their manufacturers.
They are two gut hormones involved in appetite and blood sugar regulation. A GLP-1 medication acts on the first. A dual GLP-1/GIP medication acts on both at once. That is the core mechanical difference between the two drug classes.
At Red Lion Clinic semaglutide is $299 for a 4 mg supply or $399 for 10 mg, and tirzepatide is $399 for 30 mg or $599 for 60 mg. Every price includes the provider's care, ongoing check-ins and free shipping, and there is no subscription.
That is a conversation to have with your provider rather than a decision to make on your own. Switching involves restarting dose titration, and whether it makes sense depends on why you want to change.
Yes. Both are prescription medications, and a licensed provider has to review your health history and decide treatment is appropriate before anything is dispensed.
Take the free assessment — a provider will recommend the right treatment for you.
Start your free assessment